MedTrace Logo

Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer

NCT00816452 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2010-11-03

No results posted yet for this study

Summary

Patients with prostate cancer treated in outpatient clinics will be recruited by their urologist physician.

Primary Objective: To evaluate the compliance in male patients with prostate cancer treated with Bisphosphonate and that suffered from Osteopenia/osteoporosis.

Secondary objectives:

To evaluate the compliance of family physicians to prescribe Bisphosphonate for patients upon recommendation by Urologists.

To evaluate the overall number of patients treated by Bisphosphonate in the out-patient clinics, To evaluate incidence of osteopenia/osteoporosis in this study population.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Nurit Tweezer · Sanofi-aventis administrative office Israel

Eligibility

Min Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00816452 on ClinicalTrials.gov